Global Statin Market 2015 - Market Size, Share, Growth & Opportunities

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Statin Market 2015-2019 Growth, Global
Share, Industry Overview, Analysis, Trends
Opportunities and Forecast
2
Description
Report Overview
About Statin   Statin is a structural analog of
HMG-CoA enzyme and is effective in reducing LDL.
It shows its pharmaceutical action by inhibiting
the key enzyme involved in cholesterol synthesis,
which is called HMG-CoA reductase. Therefore,
statin is referred to HMG-CoA reductase
inhibitors. Statin has been associated with a
beneficial effect on cardiovascular morbidity and
mortality. It has significant anti-inflammatory
and plaque-stabilizing effects. Its other effects
include decreased oxidative stress and vascular
inflammation with increased atherosclerotic
lesions. Some of the currently available statins
are atorvastatin, lovastatin, rosuvastatin, and
simvastatin.   The global statin market to
decline at a CAGR of 7.50 over the period
2014-2019.   Read more details at
http//www.bigmarketresearch.com/global-statin-201
5-2019-market
3
Key Benefits
Summery
Covered in this Report   Global Statin Market,
report covers the present scenario and the growth
prospects of the global statin market for the
period 2015-2019. To calculate the market size,
the report considers revenue generated from the
sales of statins used for the management of lipid
abnormalities and lipid-associated comorbidities
such as stroke and coronary heart disease. This
report provides a discussion of the market in the
following three regions Americas, APAC, and
EMEA.   Global Statin Market 2015-2019, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the market landscape and its growth
prospects in the coming years. The report
includes a discussion of the key vendors
operating in this market.
4
Key Audiences
Key Regions Americas APAC EMEA Key
Vendors AstraZeneca Merck Novartis  Other
Prominent Vendors Amgen Aurobindo Pharma
Abbvie Abbott Biocon BC World Pharm
Cipla Concord Biotech CKD Bio
5
Table Of Contents
Company Profile
Market Driver Rising Number of High Cholesterol
Cases For a full, detailed list, view our
report   Market Challenge Lack of Novel
Molecules in Statins Category For a full,
detailed list, view our report   Market Trend
Switch from Statins to Non-statins For a full,
detailed list, view our report Enquire about
report http//www.bigmarketresearch.com/report-en
quiry/250851
6
Get Full Information At http//www.bigmarketrese
arch.com/global-statin-2015-2019-market